Paricalcitol for Secondary Hyperparathyroidism in Renal Transplantation

Secondary hyperparathyroidism contributes to post-transplant CKD mineral and bone disorder. Paricalcitol, a selective vitamin D receptor activator, decreased serum parathyroid hormone levels and proteinuria in patients with secondary hyperparathyroidism. This single-center, prospective, randomized,...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Am Soc Nephrol
Prif Awduron: Trillini, Matias, Cortinovis, Monica, Ruggenenti, Piero, Reyes Loaeza, Jorge, Courville, Karen, Ferrer-Siles, Claudia, Prandini, Silvia, Gaspari, Flavio, Cannata, Antonio, Villa, Alessandro, Perna, Annalisa, Gotti, Eliana, Caruso, Maria Rosa, Martinetti, Davide, Remuzzi, Giuseppe, Perico, Norberto
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Nephrology 2015
Pynciau:
Clinical Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4413751/
https://ncbi.nlm.nih.gov/pubmed/25194004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2013111185
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg